Since the NCI Site Visit to the UNM Cancer Center in May 2005 and receipt of the detailed CCSG review. The University of New Mexico Cancer Center has undertaken very extensive internal planning and evaluation. The Cancer Center initiated a strategic planning process to improve evaluation of the Cancer Center. We have held four full meetings of our UNM Cancer Center External Scientific Advisory Board (ESAB) in: November 2006, June 2007, and May 2008 and May, 2009. In addition, we have coordinated several visits to our institution from individual members of our ESAB or other invited experts to review each program or special activity. We have focused our analyses on our overall strategic plans and on the strengths, weaknesses, opportunities, focus, and design of each of our Research Programs, their Associated Clinical Working Groups, and our Shared Resources. We have carefully considered the detailed critiques provided by the NCI Review Panel for our P30 CCSG and our ESAB and individual consultants. We have had weekly meetings of the UNM Cancer Center Senior Leadership group for the past year and regular meetings of the Cancer Center Research Program, Clinical Working Group, and Shared Resource Directors. We have also activated an institution-wide Cancer Center Seminar Series held the 3rd and 4th Tuesday of each month, where selected Program Members present highlights of their science. This very popular luncheon seminar regulariy attracts over 50 Cancer Center-associated faculty as well as other faculty and staff from the Health Sciences Center;the series has further enhanced awareness and interactions among excellent program scientists. We have described our ongoing planning and evaluation activities in some detail in the Director's Scientific Overview (Section 6) and each of the Research Program Reports (Section 8). As previously described, over the past 4 years, we have made changes in our Senior Leadership, have appointed new Program Leaders, and have adjusted the focus and scope of our Research Programs, particulariy in Cancer Biology &Biotechnology. In part due to anticipation of our competitive renewal, we have also completed a new 5 year detailed Strategic Plan for the next phase of development of our Center overall, with specific plans for each of our Programs and Resources.
UNM Cancer Center planning and evaluation processes are to responsive external review which facilitate the identification of areas of strength, weakness and opportunities and their incorporation into strategic planning.
|Flook, Adam M; Yang, Jianquan; Miao, Yubin (2014) Substitution of the Lys linker with the ?-Ala linker dramatically decreased the renal uptake of 99mTc-labeled Arg-X-Asp-conjugated and X-Ala-Asp-conjugated ?-melanocyte stimulating hormone peptides. J Med Chem 57:9010-8|
|Davies, Suzy; Holmes, Anna; Lomo, Lesley et al. (2014) High incidence of ErbB3, ErbB4, and MET expression in ovarian cancer. Int J Gynecol Pathol 33:402-10|
|Wu, Yang; Tapia, Phillip H; Jarvik, Jonathan et al. (2014) Real-time detection of protein trafficking with high-throughput flow cytometry (HTFC) and fluorogen-activating protein (FAP) base biosensor. Curr Protoc Cytom 67:Unit 9.43.|
|Morris, K T; Khan, H; Ahmad, A et al. (2014) G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration. Br J Cancer 110:1211-20|
|Vaughan, Roger A; Gannon, Nicholas P; Garcia-Smith, Randi et al. (2014) ?-alanine suppresses malignant breast epithelial cell aggressiveness through alterations in metabolism and cellular acidity in vitro. Mol Cancer 13:14|
|Lu, Jie; Hathaway, Helen J; Royce, Melanie E et al. (2014) Introduction of D-phenylalanine enhanced the receptor binding affinities of gonadotropin-releasing hormone peptides. Bioorg Med Chem Lett 24:725-30|
|Campen, Matthew J; Paffett, Michael L; Colombo, E Sage et al. (2014) Muscle RING finger-1 promotes a maladaptive phenotype in chronic hypoxia-induced right ventricular remodeling. PLoS One 9:e97084|
|Yang, Jianquan; Flook, Adam M; Feng, Changjian et al. (2014) Linker modification reduced the renal uptake of technetium-99m-labeled Arg-Ala-Asp-conjugated alpha-melanocyte stimulating hormone peptide. Bioorg Med Chem Lett 24:195-8|
|Hill, Jeff W; Thompson, Jeffrey F; Carter, Mark B et al. (2014) Identification of isoxsuprine hydrochloride as a neuroprotectant in ischemic stroke through cell-based high-throughput screening. PLoS One 9:e96761|
|Scaling, Allison L; Prossnitz, Eric R; Hathaway, Helen J (2014) GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast. Horm Cancer 5:146-60|
Showing the most recent 10 out of 123 publications